ELTP ELITE PHARMACEUTICALS INC
- 0.585
- +0.085+17.00%
ELITE PHARMACEUTICALS INC News
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 ended June 30, 2024 and Provides Conference Call Information Conference Call Scheduled for Thursday, August 15 at 11:30 AM EDT
ELITE PHARMACEUTICALS INC | 10-Q: Q1 2025 Earnings Report
ELITE PHARMACEUTICALS INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 10-K: FY2024 Annual Report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 8-K: Current report
ELITE PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities-Officer Hakim Nasrat A
ELITE PHARMACEUTICALS INC | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Hakim Nasrat A
ELITE PHARMACEUTICALS INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ELITE PHARMACEUTICALS INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ELITE PHARMACEUTICALS INC | UPLOAD: Others
ELITE PHARMACEUTICALS INC | CORRESP: CORRESP
ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
ELITE PHARMACEUTICALS INC | 10-Q: Q3 2024 Earnings Report
ELITE PHARMACEUTICALS INC | UPLOAD: Others
Analysis
Price Target
No Data
No Data